Group 1: Company Performance - Oddity Tech Ltd. reported a 24% year-over-year revenue increase to $148 million in Q3 2025, with a simultaneous 24% rise in adjusted diluted EPS [2] - The company's growth was driven by a 40% year-over-year surge in international revenue, particularly in established markets like the UK and Australia [2] - Oddity is testing new markets in France, Italy, and Spain as part of its international expansion strategy [2] Group 2: Financial Guidance - Oddity raised its full-year 2025 revenue guidance, now forecasting total revenue between $806 million and $809 million, representing 24% to 25% growth [3] - The adjusted diluted EPS is projected to be in the range of $2.10 to $2.12 for the full year [3] Group 3: Strategic Developments - A major highlight of the quarter was the launch of METHODIQ, a new dermatology-focused medical care brand, expected to scale faster than the previous successful launch of SpoiledChild [3] - Although METHODIQ is anticipated to initially carry lower gross margins due to third-party physician network costs, management remains optimistic about its growth potential [3] Group 4: Analyst Ratings - JPMorgan analyst Cory Carpenter lowered the price target on Oddity to $59 from $67 while maintaining an Overweight rating on the shares [1] - The firm updated its investment ratings and price targets for companies within the small- and mid-cap internet and video game sectors as part of its 2026 market forecast [1]

Group 1 - Oddity Tech (ODD) shares have increased by 7.2% over the past four weeks, closing at $42.4, with a mean price target of $66.82 indicating a potential upside of 57.6% [1] - The mean estimate consists of 11 short-term price targets with a standard deviation of $12.63, where the lowest estimate is $46.00 (8.5% increase) and the highest is $80.00 (88.7% increase) [2] - Analysts show strong agreement on ODD's ability to report better earnings, with a positive trend in earnings estimate revisions correlating with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for ODD's current year has risen by 1.6% over the past month, with two estimates increasing and no negative revisions [12] - ODD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [14]

Group 1 - The article discusses Oddity Tech (ODD) and highlights a strong growth potential supported by a significant competitive advantage and an expanding international presence [1] - The author previously assigned a buy rating to ODD, indicating confidence in the company's future performance [1] - The author emphasizes a diverse investment strategy that incorporates fundamental, technical, and momentum investing approaches to enhance investment decision-making [1] Group 2 - The article serves as a platform for tracking investment ideas and connecting with like-minded investors [1]

Core Viewpoint - Vanguard Mining Corp. has engaged Hardline Exploration Ltd. to prepare an NI 43-101 Technical Report for its Brussels Creek Gold-Copper-Palladium Project, marking a significant step in advancing the project towards further exploration [1][2]. Project Development - The Brussels Creek Project is located in the Kamloops Mining District of British Columbia and is 100% owned by Vanguard Mining [1]. - A comprehensive surface sampling program was recently completed, with assay results pending, and the NI 43-101 Technical Report is expected to be finalized by the end of January 2026 [2][3]. - The 2025 sampling program followed up on a previous drill intercept of 5.08 g/tonne gold over 3.5 meters, reported in 2023, and included 21 rock samples and 127 soil samples [4]. Sampling and Analysis - All samples were sent to SGS Canada Inc. for analysis, utilizing industry-standard methods for gold and platinum group metals [5][8]. - The analytical results will be compiled and reviewed by the company's Qualified Person, with a focus on prioritizing targets for a potential 2026 drilling program [6]. Strategic Importance - The Brussels Creek Project is strategically located adjacent to New Gold Inc.'s New Afton Mine, enhancing its exploration potential within the prolific Quesnel Terrane [14]. - The region's strategic importance has been underscored by Coeur Mining Inc.'s recent acquisition of New Gold Inc. for US$7 billion, creating a combined mining company valued at US$20 billion [13]. Community Engagement - Vanguard Mining is committed to collaborating with the Stk'emlúpsemc te Secwépemc Nation, focusing on local employment, environmental stewardship, and transparent engagement throughout exploration activities [16]. Historical Context - Historical sampling from 1983-1984 identified a 200 m × 400 m anomalous zone with gold values up to 3.5 g/t, and recent grab samples have confirmed high-grade surface mineralization [19].

Core Viewpoint - Oddity Tech (ODD) shows potential for significant upside, with a mean price target of $68 indicating a 57.6% increase from its current price of $43.14 [1] Price Targets and Analyst Estimates - The mean estimate consists of 11 short-term price targets, with a standard deviation of $11.73, indicating variability among analysts [2] - The lowest estimate is $46.00, suggesting a 6.6% increase, while the highest estimate is $80.00, indicating an 85.4% potential surge [2] - A low standard deviation signifies strong agreement among analysts regarding the stock's price direction [9] Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about ODD's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 1.6%, with two estimates moving higher and no negative revisions [12] - ODD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on price targets for investment decisions may not be prudent, as analysts' ability to set unbiased targets has been questioned [3][7] - Analysts often set optimistic price targets due to business incentives, which can lead to inflated estimates [8] - While price targets should not be ignored, they should be approached with skepticism, as they may not accurately reflect potential returns [10]

Core Insights - The focus is on identifying quality companies at reasonable valuations, emphasizing the importance of fundamentals in driving long-term share prices [1] Group 1 - The investor is inspired by notable figures such as Warren Buffett, Peter Lynch, and Terry Smith, indicating a preference for established investment philosophies [1] - The strategy involves predicting earnings per share as a key metric for assessing business performance [1]

Company Overview - Oddity Tech, trading under NASDAQ:ODD, is recognized for its innovative beauty brands, Il Makiage and SpoiledChild, which have gained popularity due to their strong online presence and unique product offerings [1] - The company operates in the competitive beauty and skincare industry, facing competition from major players like Estée Lauder and L'Oréal [1] Financial Performance - Oddity's net revenue increased by 24% year over year, reaching $148 million, driven by strong online sales for its brands [3] - The company's gross margin improved to 71.6%, up from 69.9% the previous year, indicating effective cost management [3][6] - Adjusted net income soared by 26% to $25 million, or $0.40 per share, surpassing Wall Street's forecast of $0.35 per share [4][6] Market Activity - Following a price target set by Truist Financial at $80, indicating a potential increase of about 84.71%, ODD shares surged over 10% by midday [2][6] - The current stock price is $39.57, reflecting a 6.49% increase, with a market capitalization of approximately $2.25 billion [5]

Core Insights - Polen Capital's "Polen U.S. Small Cap Growth Strategy" achieved a return of 21.4% gross and 21.1% net of fees in Q3 2025, outperforming the Russell 2000 Growth Index which returned 12.2% [1] Company Overview - Oddity Tech Ltd. (NASDAQ:ODD) is a consumer tech company focused on building digital-first brands in the beauty and wellness sectors [2][3] - The stock of Oddity Tech Ltd. closed at $37.16 on November 19, 2025, with a market capitalization of $2.04 billion [2] Performance Analysis - Oddity Tech Ltd. had a one-month return of -7.51% and a 52-week gain of 1.07% [2] - It was identified as a significant detractor from the portfolio's relative performance in Q3 2025, alongside Carpenter Technology and TransMedics Group [3] Investment Sentiment - Oddity Tech Ltd. was held by 36 hedge fund portfolios at the end of Q2 2025, an increase from 23 in the previous quarter [4] - Despite its potential, the company is not considered among the top 30 most popular stocks among hedge funds, with analysts suggesting that other AI stocks may offer better upside potential with less downside risk [4]

Financial Data and Key Metrics Changes - The company reported a 24% year-over-year revenue growth, reaching $148 million in Q3 2025, exceeding guidance of 21% to 23% [16][19] - Adjusted diluted earnings per share increased to $0.40, surpassing guidance of $0.33 to $0.36 [18] - Gross margins expanded to 71.6%, up 170 basis points from the previous year, exceeding guidance of 68% [17] - Adjusted EBITDA for the quarter was $29 million, above the guidance of $26 million to $28 million [18] Business Line Data and Key Metrics Changes - Il Makiage experienced double-digit online revenue growth, with a target of $1 billion revenue by 2028 [11] - SpoiledChild is expected to generate $225 million in revenue for 2025, indicating strong performance [12] - International revenue increased approximately 40% year-over-year in the first nine months of 2025, with successful scaling in existing markets [11] Market Data and Key Metrics Changes - The company noted that 83% of revenue still comes from the U.S., with international markets contributing 17% [23] - New geographic expansions include Italy, Spain, Netherlands, Ireland, Sweden, and Denmark, with testing in Japan, Mexico, and Korea [24] Company Strategy and Development Direction - The launch of Methodic, a new brand focused on dermatology, aims to transform medical care with high-efficacy treatments [5][6] - The company plans to expand Methodic into new medical domains beyond dermatology in the future [7] - Continued investment in technology and innovation, particularly in AI and proprietary datasets, is a key focus for driving direct-to-consumer growth [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate a challenging industry backdrop, citing strong repeat customer rates as a buffer against acquisition cost increases [40] - The outlook for 2025 has been raised, with expected net revenue between $806 million and $809 million, representing 24% to 25% year-over-year growth [19] Other Important Information - The company ended the quarter with $793 million in cash and cash equivalents, plus an additional $200 million available on undrawn credit facilities [19] - Methodic's launch includes a significant media campaign, marking the largest TikTok activation in the company's history [10] Q&A Session Summary Question: Can you unpack the 40% year-to-date growth in international markets? - Management noted that 83% of revenue still comes from the U.S., with international growth being strategically important and focused on existing markets [23][24] Question: Thoughts on Methodic's ability to bring in new customers? - Management indicated that Methodic will attract both new and existing customers, with a mixed approach to user acquisition [25][27] Question: How to think about Methodic's brand for 2026? - Expectations are for Methodic to scale faster than SpoiledChild, with a focus on user acquisition and long-term growth [32][34] Question: Views on the health of the U.S. consumer? - Management acknowledged external softness but highlighted strong internal performance and repeat customer growth as mitigating factors [40] Question: Is the growth algorithm for 2026 any different? - No changes to the growth algorithm of 20% revenue growth and 20% adjusted EBITDA margin were indicated [42] Question: How replicable is the data model for international efforts? - Management confirmed a measured approach for Methodic, starting only in the U.S. before considering international expansion [64] Question: Are the molecules for Methodic prescription or non-prescription? - The initial products will be a combination of OTC and cosmetic, with a focus on non-prescription offerings [67][93] Question: What is the total addressable market (TAM) for Methodic? - The TAM is viewed in terms of the number of people suffering from chronic skin conditions, with a focus on improving access and outcomes [84]

Financial Data and Key Metrics Changes - ODDITY reported a 24% year-over-year revenue growth in Q3, reaching $148 million, exceeding guidance of 21% to 23% growth [16][19] - Adjusted diluted earnings per share increased to $0.40, surpassing guidance of $0.33 to $0.36 [18] - Gross margins expanded to 71.6%, up 170 basis points from the previous year, exceeding guidance of 68% [17] Business Line Data and Key Metrics Changes - Il Makiage experienced double-digit online revenue growth, with a target of $1 billion revenue by 2028 [11] - SpoiledChild is expected to generate $225 million in revenue for 2025, showing strong performance [12] - METHODIQ, the new brand, aims to launch 28 products addressing various skin conditions, with a focus on dermatology [8][9] Market Data and Key Metrics Changes - International revenue increased approximately 40% year-over-year in the first nine months of 2025, with significant growth in existing markets like the U.K. and Australia [11][24] - The U.S. still accounts for 83% of total revenue, indicating room for international expansion [23] Company Strategy and Development Direction - ODDITY is focused on expanding its international presence while responsibly managing growth across brands and geographies [23] - The company aims to leverage technology and innovation, particularly through ODDITY Labs, to enhance product offerings and consumer experience [14][52] - METHODIQ is positioned to transform the medical care system by providing high-efficacy treatments without traditional barriers [6][7] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges in the industry but emphasized strong financial performance and growth potential [5][16] - The company raised its full-year guidance, expecting net revenue between $806 million and $809 million for 2025, representing 24% to 25% growth [19] - Management remains optimistic about the consumer environment, citing strong repeat purchase rates as a buffer against acquisition cost increases [40] Other Important Information - ODDITY plans to launch a major media campaign for METHODIQ, including a significant TikTok activation [10][89] - The company has a strong cash position with $793 million in cash and equivalents, plus $200 million available on undrawn credit facilities [19][60] Q&A Session Summary Question: Can you unpack the 40% year-to-date growth in international markets? - Management noted that 83% of revenue still comes from the U.S., with international growth primarily from existing markets like Canada and the U.K. [23][24] Question: How does METHODIQ plan to attract new customers? - METHODIQ is expected to draw customers from existing brands while also focusing on user acquisition [27] Question: What is the growth outlook for Il Makiage and SpoiledChild? - Management aims for sustained 20% growth across brands, with Il Makiage targeting $1 billion by 2028 [75] Question: How is the company addressing higher acquisition costs? - Management highlighted strong repeat purchase rates as a key factor in offsetting higher acquisition costs [40] Question: What is the financial profile of METHODIQ? - METHODIQ is expected to have a similar long-term growth framework as Il Makiage and SpoiledChild, with a focus on repeat business [50] Question: How will the company leverage its physician network for METHODIQ? - The company is currently using third-party networks for physicians and plans to integrate technology to enhance treatment outcomes [67]